194P Thermal ablation followed by intratumoral injection of a novel immune stimulant IP-001 in patients with advanced solid tumors: Phase IB part of study SAKK 66/17. (December 2022) - Joerger, M.; Knüsel, P.; Alejandre-Lafont, E.; Metaxas, Y.; Mark, M.T.; von Moos, R.A.F.; Gysel, K.; Eckhardt, K.; Glaus Garzon, J.; Koster, K-L.; Wittwer, Y.; Tissot, S.; et al.